BioCentury
ARTICLE | Finance

U.K. cash catalyst

Non-U.K. biotechs tap Biomedical Catalyst funds through U.K. R&D subsidiaries

March 18, 2013 7:00 AM UTC

A pair of non-British companies tapped into U.K. government largesse last week when they received awards from the U.K. Technology Strategy Board's Biomedical Catalyst fund.

All told, 43 companies and eight universities received £47.2 million ($70.5 million) in awards...